Defensin-related peptide 1 (Defr1) is allelic to Defb8 and chemoattracts immature DC and CD4+ T cells independently of CCR6

β‐Defensins comprise a family of cationic, antimicrobial and chemoattractant peptides. The six cysteine canonical motif is retained throughout evolution and the disulphide connectivities stabilise the conserved monomer structure. A murine β‐defensin gene (Defr1) present in the main defensin cluster of C57B1/6 mice, encodes a peptide with only five of the canonical six cysteine residues. In other inbred strains of mice, the allele encodes Defb8, which has the six cysteine motif. We show here that in common with six cysteine β‐defensins, defensin‐related peptide 1 (Defr1) displays chemoattractant activity for CD4+ T cells and immature DC (iDC), but not mature DC cells or neutrophils. Murine Defb2 replicates this pattern of attraction. Defb8 is also able to attract iDC but not mature DC. Synthetic analogues of Defr1 with the six cysteines restored (Defr1 Y5C) or with only a single cysteine (Defr1‐1cV) chemoattract CD4+ T cells with reduced activity, but do not chemoattract DC. β‐Defensins have previously been shown to attract iDC through CC receptor 6 (CCR6) but neither Defr1 or its related peptides nor Defb8, chemoattract cells overexpressing CCR6. Thus, we demonstrate that the canonical six cysteines of β‐defensins are not required for the chemoattractant activity of Defr1 and that neither Defr1 nor the six cysteine polymorphic variant allele Defb8, act through CCR6.

[1]  D. Uhrín,et al.  Analysis and Separation of Residues Important for the Chemoattractant and Antimicrobial Activities of β-Defensin 3* , 2008, Journal of Biological Chemistry.

[2]  T. Hehlgans,et al.  Identification and Biological Characterization of Mouse β-Defensin 14, the Orthologue of Human β-Defensin 3* , 2008, Journal of Biological Chemistry.

[3]  G. Barsh,et al.  A β-Defensin Mutation Causes Black Coat Color in Domestic Dogs , 2007, Science.

[4]  R. Mott A haplotype map for the laboratory mouse , 2007, Nature Genetics.

[5]  A. Soruri,et al.  β‐Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved , 2007, European journal of immunology.

[6]  Eleazar Eskin,et al.  A sequence-based variation map of 8.27 million SNPs in inbred mouse strains , 2007, Nature.

[7]  C. Albanesi,et al.  IL-4 and IL-13 Negatively Regulate TNF-α- and IFN-γ-Induced β-Defensin Expression through STAT-6, Suppressor of Cytokine Signaling (SOCS)-1, and SOCS-31 , 2007, The Journal of Immunology.

[8]  P. Barran,et al.  Covalent Dimer Species of β-Defensin Defr1 Display Potent Antimicrobial Activity against Multidrug-Resistant Bacterial Pathogens , 2007, Antimicrobial Agents and Chemotherapy.

[9]  F. Blecha,et al.  Cross-species analysis of the mammalian beta-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract. , 2005, Physiological genomics.

[10]  C. Semple,et al.  The complexity of selection at the major primate β-defensin locus , 2005, BMC Evolutionary Biology.

[11]  I. Nagaoka,et al.  Human β‐defensin‐2 functions as a chemotactic agent for tumour necrosis factor‐α‐treated human neutrophils , 2004 .

[12]  T. Ganz Faculty Opinions recommendation of Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. , 2003 .

[13]  D. Hoover,et al.  Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human β-defensin 3 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  L. Kwak,et al.  Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2 , 2002, Science.

[15]  D. Hoover,et al.  The Structure of Human Macrophage Inflammatory Protein-3α/CCL20 , 2002, The Journal of Biological Chemistry.

[16]  S. Cross,et al.  Identification and characterization of a novel murine beta-defensin-related gene , 2002, Mammalian Genome.

[17]  L. Kwak,et al.  Mammalian defensins in immunity: more than just microbicidal. , 2002, Trends in immunology.

[18]  L. Kwak,et al.  Mediators of Innate Immunity That Target Immature, But Not Mature, Dendritic Cells Induce Antitumor Immunity When Genetically Fused with Nonimmunogenic Tumor Antigens , 2001, The Journal of Immunology.

[19]  H. Sticht,et al.  Structure determination of human and murine β‐defensins reveals structural conservation in the absence of significant sequence similarity , 2001, Protein science : a publication of the Protein Society.

[20]  O. Chertov,et al.  Participation of mammalian defensins and cathelicidins in anti‐microbial immunity: receptors and activities of human defensins and cathelicidin (LL‐37) , 2001, Journal of leukocyte biology.

[21]  J. Schröder,et al.  Isolation and Characterization of Human β-Defensin-3, a Novel Human Inducible Peptide Antibiotic* , 2001, The Journal of Biological Chemistry.

[22]  Ji Ming Wang,et al.  β-Defensins: Linking Innate and Adaptive Immunity Through Dendritic and T Cell CCR6 , 1999 .

[23]  C. Watts Immunology Inside the gearbox of the dendritic cell , 1997, Nature.

[24]  R. Steinman,et al.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.

[25]  C. Albanesi,et al.  IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. , 2007, Journal of immunology.

[26]  D. Hoover,et al.  Human beta-defensins. , 2006, Cellular and molecular life sciences : CMLS.

[27]  C. Semple,et al.  The complexity of selection at the major primate beta-defensin locus , 2005 .

[28]  Josefina Garcia Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A , 2004 .

[29]  I. Nagaoka,et al.  Human beta-defensin-2 functions as a chemotactic agent for tumour necrosis factor-alpha-treated human neutrophils. , 2004, Immunology.

[30]  L. Kwak,et al.  Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. , 2002, Science.

[31]  D. Hoover,et al.  The Structure of Human MIP-3 (cid:1) /CCL20: Linking Antimicrobial and CCR6 Receptor Binding Activities with Human (cid:2) -Defensins , 2002 .